News

The Members of the International Generic Drug Regulators Programme (IGDRP) participated in its 4th meeting held in Mexico, from 17 to 20 October 2016. The Members focused primarily on the future

The Management Committee (MC) of the International Pharmaceutical Regulators Forum (IPRF) met in Osaka, Japan, November 6-7, 2016. During this meeting, the MC endorsed elements for a long-term

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Lisbon, Portugal, June 12-13,  2016. It continued a strategy development process that had been

The 3rd meeting of the International Generic Drug Regulators Programme (IGDRP) was held in Strasbourg, France, from 9-12 May 2016, the primary focus of the meeting being the resolution of barriers to

The Biowaivers Working Group held a face to face meeting on 2-3 November 2015 as part of the 2nd meeting of the International Generic Drug Regulators Programme (IGDRP) in Seoul, South Korea, with a

With a view to improving international cooperation and work-sharing in the assessment of ASMF/DMF for generic drugs, the members of the ASMF/DMF Working Group held a face to face meeting as part of

The Management Committee of the International Pharmaceutical Regulators Forum (IPRF) met in Jacksonville, Florida, US, on 7 and 8 December 2015. Within the two and a half years after its establishment

The 2nd meeting of the International Generic Drug Regulators Programme (IGDRP) was held in Seoul, South Korea from 4-5 November 2015, with resolution of barriers to progress work-sharing and

The IGDRP Biowaivers working group was formed in May 2013 with the objective of establishing a common set of conditions for the granting of biowaivers as well as the expansion of the application of

The IGDRP ASMF/DMF working group was formed in May 2013 to foster international collaboration and worksharing in the area of evaluations for ASMFs/DMFs during the review of a generic drug product.